CMV sinusitis in a HIV-negative renal transplant recipient.
1Department of Renal Medicine Alfred Hospital, Melbourne, Australia 2Department of Infectious Diseases Alfred Hospital, Melbourne, Australia 3Department of Anatomical Pathology Alfred Hospital Melbourne, Australia.
Anuksha
A
Gujadhur
Napier
N
Thomson
Ar Kar
AK
Aung
Catriona
C
Mclean
Solomon
S
Menahem
D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D000077552:Basiliximab; D003587:Cytomegalovirus; D003586:Cytomegalovirus Infections / Q000150:complications / Q000175:diagnosis*; D005260:Female; D015774:Ganciclovir / Q000031:analogs & derivatives / Q000627:therapeutic use; D005922:Glomerulonephritis, IGA / Q000276:immunology; D018023:HIV Seronegativity; D006801:Humans; D007165:Immunosuppression Therapy; D007249:Inflammation; D016030:Kidney Transplantation; D008875:Middle Aged; D009173:Mycophenolic Acid / Q000008:administration & dosage / Q000031:analogs & derivatives; D011239:Prednisolone / Q000008:administration & dosage; D011993:Recombinant Fusion Proteins / Q000008:administration & dosage; D006435:Renal Dialysis; D051437:Renal Insufficiency / Q000150:complications / Q000628:therapy*; D012852:Sinusitis / Q000150:complications / Q000821:virology*; D016559:Tacrolimus / Q000008:administration & dosage; D000077562:Valganciclovir
D000911:Antibodies, Monoclonal; D011993:Recombinant Fusion Proteins; D000077552:Basiliximab; D011239:Prednisolone; D000077562:Valganciclovir; D009173:Mycophenolic Acid; D015774:Ganciclovir; D016559:Tacrolimus